// App-Quantinova.ai

585 : Assessing ENPP3 as a renal cancer target for bispecific T-cell engager (BiTE) therapy

Researchers

Presenter

  • Olivier Nolan-Stevaux

Principal Investigators

  • Flordeliza Fajardo

  • Lily Liu

  • Suzanne Coberly

  • Patricia McElroy

  • Aaron Nazarian

  • Franziska Bott

  • Elisabeth Nahrwold

  • Tobias Raum

  • Roman Kischel

  • Ralf Lutterbuese

  • Patrick Hoffmann

  • Peter Kufer

Medical Centers

  • Amgen Inc, South San Francisco, CA

  • Amgen Inc, Thousand Oaks, CA

  • Amgen, Inc., Munich, Germany

Locations

  • United States

  • Germany

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

  • Renal cell carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved